Sorafenib and Letrozole, Anastrozole, or Exemestane in Treating Postmenopausal Women With Estrogen Receptor-Positive and/or Progesterone Receptor-Positive Metastatic Breast Cancer

NCT00573755 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped lack of participant accrual

Conditions

Breast Cancer

Interventions

DRUG: anastrozole
DRUG: exemestane
DRUG: letrozole
DRUG: sorafenib tosylate
OTHER: placebo

Sponsor

Mayo Clinic

Collaborators

[object Object]